Lisa M. McShane

Research interests

Publications

• Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO–College of American Pathologists Guideline Update

  Journal of Clinical Oncology · 2023 · 10.1200/jco.22.02864

• Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update

  Archives of Pathology & Laboratory Medicine · 2020 · https://doi.org/10.5858/arpa.2019-0904-sa

• Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

  JNCI Journal of the National Cancer Institute · 2020 · 10.1093/jnci/djaa201

• Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

  Journal of Clinical Oncology · 2020 · https://doi.org/10.1200/jco.19.02309

• Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W

  Journal of Clinical Oncology · 2020 · https://doi.org/10.1200/jco.19.02630

• Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

  Journal of Clinical Oncology · 2018 · https://doi.org/10.1200/jco.2018.77.8738

• Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

  Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2015.65.2289

• Imaging biomarker roadmap for cancer studies

  Nature Reviews Clinical Oncology · 2016 · https://doi.org/10.1038/nrclinonc.2016.162

• An international study to increase concordance in Ki67 scoring

  Modern Pathology · 2015 · https://doi.org/10.1038/modpathol.2015.38

• An International Ki67 Reproducibility Study

  JNCI Journal of the National Cancer Institute · 2013 · https://doi.org/10.1093/jnci/djt306

• Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

  Journal of Clinical Oncology · 2013 · https://doi.org/10.1200/jco.2013.50.9984

• Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration

  PLoS Medicine · 2012 · 10.1371/journal.pmed.1001216

• Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

  JNCI Journal of the National Cancer Institute · 2011 · 10.1093/jnci/djr393

• American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

  Journal of Clinical Oncology · 2010 · 10.1200/jco.2009.25.6529

• Randomized Clinical Trials With Biomarkers: Design Issues

  JNCI Journal of the National Cancer Institute · 2010 · https://doi.org/10.1093/jnci/djp477

• American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

  Archives of Pathology & Laboratory Medicine · 2010 · 10.5858/134.6.907

• American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version)

  Archives of Pathology & Laboratory Medicine · 2010 · 10.5858/134.7.e48

• American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

  Archives of Pathology & Laboratory Medicine · 2007 · https://doi.org/10.5858/2007-131-18-asocco

• REporting recommendations for tumor MARKer prognostic studies (REMARK)

  Breast Cancer Research and Treatment · 2006 · 10.1007/s10549-006-9242-8

• American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

  Journal of Clinical Oncology · 2006 · https://doi.org/10.1200/jco.2006.09.2775

• REporting recommendations for tumor MARKer prognostic studies (REMARK)

  Nature Clinical Practice Oncology · 2005 · 10.1038/ncponc0252

• Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)

  JNCI Journal of the National Cancer Institute · 2005 · https://doi.org/10.1093/jnci/dji237

• REporting recommendations for tumour MARKer prognostic studies (REMARK)

  British Journal of Cancer · 2005 · 10.1038/sj.bjc.6602678

• Reporting Recommendations for Tumor Marker Prognostic Studies

  Journal of Clinical Oncology · 2005 · 10.1200/jco.2004.01.0454

• Chromosome Transfer Induced Aneuploidy Results in Complex Dysregulation of the Cellular Transcriptome in Immortalized and Cancer Cells

  Cancer Research · 2004 · https://doi.org/10.1158/0008-5472.can-04-0474

• Pitfalls in the Use of DNA Microarray Data for Diagnostic and Prognostic Classification

  JNCI Journal of the National Cancer Institute · 2003 · 10.1093/jnci/95.1.14

• Controlling the number of false discoveries: application to high-dimensional genomic data

  Journal of Statistical Planning and Inference · 2003 · https://doi.org/10.1016/s0378-3758(03)00211-8

• Breast cancer classification and prognosis based on gene expression profiles from a population-based study

  Proceedings of the National Academy of Sciences · 2003 · 10.1073/pnas.1732912100

• Design and Analysis of DNA Microarray Investigations

  Statistics for biology and health · 2003 · https://doi.org/10.1007/b97583

• Iatrogenic Creutzfeldt–Jakob disease at the millennium

  Neurology · 2000 · https://doi.org/10.1212/wnl.55.8.1075

Current projects

No projects listed.